Table 3.
Repeated measures ANOVA and protected t-tests testing change in secondary outcome variables (anxiety symptoms and metacognitions in the GADS-R, and depressive symptoms in the BDI-II).
| Measure | Baseline (T1) | End of treatment (T2) | Follow-up (T3) | Onmibus effect | T1–T2 | T2–T3 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| M(SD) | F (df) | Part. Eta sq. | t (df) | d | t (df) | d | ||||
| GADS-R | ||||||||||
| Time spent worrying | 4.48 (2.32) | 0.75 (0.50) | 1.37 (1.03) | 5.48 (2, 6) | 0.65 | 3.09* (6) | −2.52 | 0.51 (6) | 0.42 | |
| Negative beliefs | 65.78 (18.11) | 30.0 (53.54) | 51.25 (53.44) | 0.61 (2, 6) | 0.17 | – | – | |||
| Positive beliefs | 22.69 (10.21) | 7.50 (15.00) | 7.50 (8.66) | 5.33 (2, 6) | 0.64 | 2.82* (6) | −2.31 | – | ||
| Maladaptive coping strategies | 19.25 (14.76) | 0.50 (1.00) | 4.37 (3.50) | 5.29 (2, 6) | 0.64 | 3.08* (6) | −2.51 | 0.64 (6) | 0.52 | |
| Avoidance behaviors | 7.22 (7.57) | 0 (0) | 0.87 (1.75) | 3.94 (2, 6) | 0.57 | 2.57* (6) | −2.1 | 0.31 (6) | 0.25 | |
| BDI-II | ||||||||||
| Depressive symptoms | 17.00 (3.56) | 4.25 (3.50) | 6.25 (5.56) | 12.75 (2, 6) | 0.81 | 4.69** (6) | −3.83 | 0.74 (6) | 0.6 | |
*
p < 0.05;
**
p < 0.01.
Dashes indicate that the analysis was not performed given that the omnibus effect was not significant or the t-test was trivial given that means to be compared were identical.